LG Display Co. Ltd. (LPL)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| April 26, 2022 | $0.26 | 2021-12-30 | 2021-12-31 |
| April 19, 2018 | $0.23 | 2017-12-28 | 2017-12-29 |
| April 20, 2017 | $0.22 | 2016-12-28 | 2016-12-30 |
| April 15, 2015 | $0.23 | 2014-12-29 | 2014-12-31 |
Dividends Summary
- LG Display Co. Ltd. has issued 4 dividend payments over the past 7 years
- The most recent dividend was paid 1243 days ago, on April 26, 2022
- The highest dividend payed out to investors during this period was $0.263015 per share
- The average dividend paid during this period was $0.24 per share.
Company News
K Wave Media acquired Rabbit Walk, a 3D visual effects and AI-powered advertising studio, to expand its content creation capabilities and add global tech companies like Samsung and LG as new clients. The acquisition is expected to increase KWM's revenue by 25-30% in the next 12 months.
The computer peripheral industry is well-poised to benefit from growing demand for gaming accessories, touchscreen devices, and 3D-printed medical equipment. However, the industry faces macroeconomic headwinds like high inflation and interest rates, which are impacting IT spending and demand for remote work-related peripherals.
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...
The organic LED specialist just signed a new long-term material supply and licensing deal with China's largest display maker.